Join us at EuroPCR 2026
Paris, Palais des Congrès, May 19-22
Don’t miss our 5 symposia with live cases and booth activities.
Discover how structural heart therapies continue to evolve with dedicated sessions and opportunities to engage with experts.
Symposia
Symposia
Symposium
Stand F11
Symposia
How can we improve the management of aortic stenosis in 2026?
Tuesday 19 May 2026 | 13:10-14:10 | Room Maillot
Anchorperson: Francesco Saia
Discussants: Marianna Adamo, Christopher Cook, Raj Makkar, Yohei Ohno, Sebastian Zimmer
Add to calendar
F. Saia
M. Adamo
C. Cook
R. Makkar
Y. Ohno
S. Zimmer
Join us if you want:
- To gain awareness of the challenges, as well as the solutions and opportunities, associated with implementing the latest guidelines in clinical practice
- To understand the impact of timely treatment for patients with severe aortic stenosis on both patient outcomes and the healthcare system
- To explore the potential of AI‑based solutions to change current clinical practice in aortic stenosis care
When less is better - Differentiated therapies to safely achieve TR 0‑1+
Tuesday 19 May 2026 | 16:30-17:30 | Simulation Learning Room (Théâtre Havane)
Anchorperson: Fabien Praz
Spokesperson: Julien Dreyfus
Discussants: Marek Grygier, Jörg Hausleiter, Jacqueline da Rocha, Robin Le Ruz, Martin Swaans, Mirjam Wild
Add to calendar
F. Praz
J. Dreyfus
M. Grygier
J. Hausleiter
J. da Rocha
R. Le Ruz
M. Swaans
M. Wild
Join us if you want:
- To understand the benefit of a tricuspid portfolio to treat a wide range of tricuspid regurgitation patients
- To discuss the importance of achieving optimal tricuspid regurgitation reduction to 1+ or less to impact patients' outcomes
- To discover how the clover technique in tricuspid TEER can help you achieve optimal tricuspid regurgitation reduction in an evidence-, simulation-, and case-based discussion
- To discuss the key PASCAL implant features that allow for optimal outcomes
- To explore how EVOQUE TTVR is an effective treatment option with established safety profile through simulation, evidence and case insights
Symposia
Innovation in Action: Achieving Optimal Outcomes in MR
Wednesday 20 May 2026 | 12:30 –13:30 | Simulation Learning Room (Théâtre Havane)
Anchorperson: Robert Smith
Spokesperson: Marina Urena
Discussants: Myriam Akodad, Xavier Freixa, Tobias Geisler, Maria Isabel Körber, Federico De Marco
Add to calendar
R. Smith
M. Urena
M. Akodad
X. Freixa
T. Geisler
M.I. Körber
F. De Marco
Join us if you want:
- To understand the benefit of a mitral portfolio to treat a wide range of mitral regurgitation patients
- To discuss the key PASCAL Precision system features that facilitate a safe mitral TEER procedure, in evidence, simulation, and case-based discussion
- To explore how TMVR with the SAPIEN M3 system can expand treatment options for mitral regurgitation patients unsuitable for surgery or TEER, simulation, and case-based discussion
Is durability still a topic of concern for TAVI patients? What are the remaining challenges that we need to overcome?
Wednesday 20 May 2026 | 16:35-18:05 | Théâtre Bleu
Anchorperson: Thomas Cuisset
Panelists: Kentaro Hayashida, Ajay Sinhal
Discussants: Amr Abbas, Tom Cahill, Narathip Chunhamaneewat, Sam Dakwins, Øyvind Haugen Lie, Karl Poon, Tobias Rheude
Add to calendar
T. Cuisset
K. Hayashida
A. Sinhal
A. Abbas
T. Cahill
N. Chunhamaneewat
S. Dawkins
O.H. Lie
K. Poon
T. Rheude
Join us if you want:
- To understand the clinical relevance of TAVI valve durability in patients with aortic stenosis and the key factors influencing long‑term valve performance
- To explore current concepts, theories, and procedural approaches aimed at achieving optimal expansion of TAVI valves
- To gain practical insights from an educational LIVE case on the safe treatment of young patients and patients with bicuspid aortic valve disease using TAVI
Symposium
TAVI vs Surgery - Are The Latest Long-Term Data Creating A Dilemma For Aortic Stenosis Patients?
Thursday 21 May 2026 | 12:30 | Room 243
Anchorperson: Stephan Windecker
Discussants: Victoria Delgado, Jörg Kempfert, Martin Leon, Bernard Prendergast, Tobias Rheude, Giuseppe Tarantini, Hendrik Treede
Add to calendar
S. Windecker
V. Delgado
J. Kempfert
M. Leon
B. Prendergast
T. Rheude
G. Tarantini
H. Treede
Join us if you want:
- To understand the latest long-term data on TAVI and SAVR
- To explore the crucial elements to consider for lifetime management
- To learn more about design and technology that increases the durability of heart valves
Join us at our Booth (Stand F11)
Step into the latest Edwards Lifesciences' transcatheter technologies at the Edwards Booth. Find us at stand F11, 1st floor, Palais des Congrès
Challenge in interactive games
Explore our latest technologies
Delve into our clinical data
Engage in in-depth conversations about our products
Download our literature to learn more about our therapies
To receive a summary of our EuroPCR 2026 activities, recordings, slide decks and future developments, join the Edwards Lifesciences community today.
heading 3
Content goes here
Abbrevations:
TMTT: Transcatheter Mitral and Tricuspid Therapies
THV: Transcatheter Heart Valve
TR: Tricuspid Regurgitation
MR: Mitral Regurgitation
TAVI: Transcatheter Aortic Valve Implantation
TEER: Transcatheter Edge-to-Edge Repair
TTVR: Tricuspid Transcatheter Valve Replacement
TMVR: Transcatheter Mitral Valve Replacement
SAVR: Surgical Aortic Valve Replacement
Les informations présentées ne sont pas destinées aux professionnels de santé exerçant en France.
Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).